- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba rolls out in-office ultrasound
Toshiba America MedicalSystems last week unveiled Capasee, a compact ob/gyn ultrasoundsystem it is introducing into the U.S. The Tustin, CA, vendorwill market the system as a portable ultrasound scanner for privateoffice applications. Capasee has been
Toshiba America MedicalSystems last week unveiled Capasee, a compact ob/gyn ultrasoundsystem it is introducing into the U.S. The Tustin, CA, vendorwill market the system as a portable ultrasound scanner for privateoffice applications.
Capasee has been marketed in Europe and Japan and has builtup an installed base of 4000 units in those market segments sinceits introduction two years ago. Toshiba demonstrated the systemfor the first time in the U.S. at this month's American Collegeof Obstetricians and Gynecologists in Orlando, FL.
Toshiba will market Capasee to obstetricians and gynecologistswho have been unable to buy ultrasound systems from major manufacturersdue to cost considerations. Capasee will be priced in the mid-$30,000range. The scanner is awaiting Food and Drug Administration 510(k)clearance.
Capasee will be distributed through Imaging Associates, a Charlotte,NC, firm that specializes in marketing medical equipment to private-practicephysicians.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
